Ipca Labs Q1 profit jumps more than 3-folds to Rs 445.68 cr on robust sales
The company had posted a net profit of Rs 129.43 crore for the corresponding period of the previous fiscal, Ipca Labs said in a BSE filing
)
premium
Shares of Ipca Laboratories closed at Rs2,099.60per unit on BSE, up 7.36 per cent over previous close.
Drug firm Ipca Laboratories on Monday reported over three-fold jump in its consolidated net profit to Rs 445.68 crore for the quarter ended June due to robust sales.
Topics : IPCA Laboratories Q1 results Pharma Companies